E V Morozova Y Y Vlasova M V Pryanishnikova K V Lepik B V Afanasyev
10.4137/BMI.S22438
Biomark Insights
2015 Dec 8;10(Suppl 3):43-7.
bcr-abl mutations cml f317l mutation tki allo-sct dasatinib
NO-CC CODE
https://pubmed.ncbi.nlm.nih.gov/26673003/
Review
PMC4674012
26673003
Efficacy of Dasatinib in a CML Patient in Blast Crisis with F317L Mutation: A Case Report and Literature Review
2015